His main research interest is the study of lower respiratory tract infections including COVID-19 and tuberculosis ... British ...

More young children are catching walking pneumonia this year, as cases of the respiratory illness continue to surge around ...

GSK (GSK) continued losses for a seventh straight session as the stock closed xx% lower, at $xx on Friday. The British ...

On a Friday call with analysts, Sanofi execs pointed to an efficacy edge for its preventive and stressed that more ...

Progress in targeted signaling inhibition and immunotherapy has spurred a race to transform treatment across virtually all cancer disease sites. There is ample preclinical data pointing toward the ...

GSK (GSK) announced new preliminary data for AREXVY in adults aged 18-49 at increased risk for lower respiratory tract disease, LRTD, caused by ...

Men have higher morbidity and mortality from COVID-19 than women, possibly due to androgen receptor-regulated viral entry ...

Arexvy is currently approved for active immunization for the prevention of LRTD caused by RSV in individuals 60 years of age and older, and those 50 to 59 years of age who are at increased risk for ...

On Thursday, GSK plc (NYSE:GSK) revealed new preliminary data for Arexvy (Respiratory Syncytial Virus Vaccine, Adjuvanted) in ...

Carom seeds (ajwain) are called seeds, but they're fruit from the ajwain herb. You can eat the seeds or use them as a spice.

GSK (GSK) reported its RSV vaccine Arexvy elicited a robust immune response in people aged 18 to 49 years who were at ...

FDA has approved Abrysvo for active immunization for the prevention of lower respiratory tract disease caused by RSV.